Russia approves 2nd coronavirus vaccine after early trials
The peptide-based, two-shot vaccine, EpiVacCorona, was developed by the Vector Institute in Siberia
Full Article
Russia approves 2nd coronavirus vaccine after early trials
Hindu
0 shares
1 views
You might like
Related news coverage
COVID-19 vaccine: Infections reported among Sputnik V trial volunteers
Mid-Day
There have been instances of infection among volunteers of Sputnik V trials, the world's first registered vaccine against Covid-19..
-
NA Proactive news snapshot: CleanSpark, XPhyto Therapeutics, GGX Gold, Altamira Gold, Goldseek Resources, Mawson Gold, UPDATE …
Proactive Investors
-
NA Proactive news snapshot: CleanSpark, Newrange Gold, XPhyto Therapeutics, GGX Gold, Altamira Gold, Goldseek Resources UPDATE …
Proactive Investors
-
NA Proactive news snapshot: XPhyto Therapeutics, GGX Gold, Altamira Gold, Goldseek Resources, Mawson Gold, Innocan Pharma UPDATE…
Proactive Investors
-
NA Proactive news snapshot: Mawson Gold, Innocan Pharma, District Metals, XPhyto Therapeutics …
Proactive Investors
Advertisement
More coverage
Dangers Of Jumping The Gun On A COVID-19 Vaccine – Analysis
Eurasia Review
By Hannah Clapham*
With COVID-19 cases still rising globally, the race is on for a vaccine. Pressures are mounting to..
